Ortoma receives FDA 510 (k) clearance for OTS™ Hip in the US
Ortoma AB (publ), a trailblazer in the realm of orthopedic technology, announces that it has obtained FDA 510(k)...
Ortoma AB (publ), a trailblazer in the realm of orthopedic technology, announces that it has obtained FDA 510(k)...
Ortoma AB (publ), a trailblazer in the realm of orthopedic technology, is set to make a groundbreaking impact at...
Ortoma AB, a Swedish medical technology company, has announced that it has signed a development and distribution...
Ortoma AB (publ), a pioneer in the field of orthopedic technology, announces that two abstracts have been accepted...
Following a clinical evaluation of Ortoma’s OTS™ Hip solution, Ortoma is now working with Johnson & Johnson...
Ortoma AB (publ) will be at the American Academy of Orthopedic Surgeons, AAOS event in Las Vegas, March 7-10, 2023....
Ortoma AB (publ) (”Ortoma” or the ”Company”) has agreed on a non-binding term sheet with the DePuy Synthes family...
Ortoma AB (publ) (”Ortoma” or the ”Company”) today announces that the Company's proof-of-concept presentations of...
Ortoma AB (publ) (”Ortoma” or the ”Company”) has recently hosted a successful training session for leading Japanese...